BMJ supportive & palliative care; Sep 2017; vol.
7 (no. 3); p. 286-291
George, Reena; Prasoona, Thotampuri Shanthi; Kandasamy, Ramu; Cherian, Renitha; Celine, Thangarathi; Jeba, Jenifer; Murali, Shakila; Mathew, David
Following a case note review of 179 patients examining the relative effectiveness of topical or oral metronidazole used for
malodour in necrotic cancers, the authors suggest that their data support formulary guidelines recommending maintenance
metronidazole for recurrent malodour. They propose a protocol for metronidazole usage in managing malodour.
Fulltext available in BMJ Supportive and Palliative Care
Available in print in Arthur Rank Hospice Library, Cambridge